Literature DB >> 2545888

Characterization of avian angiotensin II cardiac receptors: coupling to mechanical activity and phosphoinositide metabolism.

K M Baker1, J A Aceto.   

Abstract

We have characterized the avian angiotensin II (AII) cardiac receptor and provide data that this receptor couples to both mechanical activity and phospholipid metabolism in the avian heart. In 10-day-old chicks, 125I-AII bound to a high affinity site (Kd = 10 nmol) and a low affinity site (Kd = 79.4 nmol) with estimated binding capacities of 531 and 1330 fmol/mg protein, respectively. The 125I-AII binding was rapid, saturable, reversible and modulated by divalent cations and guanine nucleotides. The potency order for the competitive binding of angiotensin I and II paralleled that observed for in vitro contractile force development in bioassays utilizing left atrial tissue. In avian heart, AII also produced a dose-dependent accumulation of inositol-1-phosphate which was inhibited by the angiotensin antagonist [Sar1, Ile8]AII. The data demonstrate specific avian AII cardiac receptors and provide the first evidence that these receptors couple to both mechanical activity and phosphoinositide metabolism in avian heart.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2545888     DOI: 10.1016/0022-2828(89)90648-2

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  7 in total

1.  Regulation of muscarinic acetylcholine receptor mRNA expression by activation of homologous and heterologous receptors.

Authors:  B A Habecker; N M Nathanson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

Review 2.  Cardiac alpha(1)-adrenoceptors that regulate contractile function: subtypes and subcellular signal transduction mechanisms.

Authors:  M Endoh
Journal:  Neurochem Res       Date:  1996-02       Impact factor: 3.996

3.  The increased angiotensin II (type 1) receptor density in myocardium of type 2 diabetic patients is prevented by blockade of the renin-angiotensin system.

Authors:  H Reuter; C Adam; S Grönke; C Zobel; K F Frank; J Müller-Ehmsen; J Brabender; R H G Schwinger
Journal:  Diabetologia       Date:  2006-10-19       Impact factor: 10.122

4.  Angiotensin converting enzyme inhibition in Dahl salt-sensitive rats.

Authors:  T C Peeler; K M Baker; C F Esmurdoc; M I Chernin
Journal:  Mol Cell Biochem       Date:  1991 May 29-Jun 12       Impact factor: 3.396

5.  Pharmacological characteristics of the positive inotropic effect of angiotensin II in the rabbit ventricular myocardium.

Authors:  A Ishihata; M Endoh
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

Review 6.  Emerging roles of inositol 1,4,5-trisphosphate signaling in cardiac myocytes.

Authors:  Jens Kockskämper; Aleksey V Zima; H Llewelyn Roderick; Burkert Pieske; Lothar A Blatter; Martin D Bootman
Journal:  J Mol Cell Cardiol       Date:  2008-06-15       Impact factor: 5.000

7.  Species-related differences in inotropic effects of angiotensin II in mammalian ventricular muscle: receptors, subtypes and phosphoinositide hydrolysis.

Authors:  A Ishihata; M Endoh
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.